Skip to content

MDMA: all studies

Page 272 of 346: studies 2,711 to 2,720 of 3,454, newest first. Back to the MDMA overview

Research

Psychedelics and Pro-Social Behaviors: A Perspective on Autism Spectrum Disorders

ACS Pharmacology & Translational Science February 10, 2025 Xue Wang, Cong Lin, Xiaohui Wang 5 citations

Autism Spectrum Disorders (ASD) are complex neurodevelopmental conditions characterized by deficits in social interaction, communication, and repetitive behaviors. This viewpoint explores the potential mechanisms through which psychedelics such as lysergic acid diethylamide (LSD), psilocybin, and 3,4-methylenedioxymethamphetamine (MDMA) may positively influence pro-social behaviors, focusing on...

DOI: 10.1021/acsptsci.5c00034 (opens in new tab) Mental health treatment Psychedelics Autism spectrum disorders Social cognition

Funding Success of United States Federal Grant Applications Proposing to Study Therapeutic Applications of Psychedelics: A Survey Study

Psychoactives February 5, 2025 Brian S. Barnett 7 citations

The author surveyed researchers about United States federal grant applications for therapeutic psychedelic research and their funding success. An anonymous survey was sent to corresponding authors of the 50 most-cited psychedelic research articles published after 2000 and also disseminated on Twitter. Ten researchers responded, reporting on 24 National Institutes of Health (NIH) grant...

DOI: 10.3390/psychoactives4010004 (opens in new tab) Survey research Library science Public administration

Hallucinogen-Persisting Perception Disorder in a 16-Year-Old Adolescent.

Psychopharmacology Bulletin February 3, 2025 Anna Mori-Kreiner, Arpit Aggarwal, Meelie Bordoloi 8 citations

Hallucinogen-persisting Perception Disorder (HPPD) is a rare condition characterized by the re-experiencing of one or more perceptual symptoms that an individual experienced while intoxicated with a hallucinogenic substance when the individual is sober. While there are several case reports of HPPD in adult patients, there is a scarcity of documented cases in children and adolescents. The...

DOI: 10.1016/j.biopha.2021.112295 (opens in new tab) Full text (opens in new tab) Hallucinogen-persisting perception disorder Hallucinogenic use Mental illness Polysubstance use +3

Post-traumatic stress disorder: evolving conceptualization and evidence, and future research directions.

World Psychiatry February 1, 2025 Chris R Brewin, Lukoye Atwoli, Jonathan I Bisson et al. 73 citations

The understanding of responses to traumatic events has been greatly influenced by the introduction of the diagnosis of post-traumatic stress disorder (PTSD). In this paper we review the initial versions of the diagnostic criteria for this condition and the associated epidemiological findings, including sociocultural differences. We consider evidence for post-traumatic reactions occurring in...

DOI: 10.1002/wps.21269 (opens in new tab) Full text (opens in new tab) Post‐traumatic stress disorder Community‐based interventions Complex PTSD Genetics +9

Illicit drug use among adolescents and young adults with impairments in the US: A cross-sectional analysis of the National Survey on Drug Use And Health.

Preventive medicine February 1, 2025 Justin A Haegele, Samantha M Ross-Cypcar, Jeanette M Garcia 4 citations

The purpose of this cross-sectional analysis is to compare the degree to which adolescents and adults with and without impairments in the US engage in illicit drug use. This cross-sectional study utilized data from the 2022 National Survey of Drug Use and Health. Impairment status (mobility, cognitive, hearing, vision, self-care, and communication impairments), illicit drug use (cocaine, crack,...

DOI: 10.1016/j.ypmed.2025.108222 (opens in new tab) Full text (opens in new tab) Public health policy Illicit drugs Impairment Substance abuse +3

The Acceptability of Psychedelic‐Assisted Therapy Amongst Mental Health Consumers: Utilising the Theory of Planned Behaviour

International Journal of Mental Health Nursing February 1, 2025 Eva Louie, Ellen Towers, Alyssa R Morse et al. 2 citations

ABSTRACT Australian government approval has been granted for 3,4‐methylenedioxy‐methamphetamine (MDMA) treatment of post‐traumatic stress disorder and psilocybin for treatment‐resistant depression, but the process of translating psychedelic‐assisted therapies (PAT) into more widespread use is complex. Along with establishing the efficacy and feasibility of PATs, their acceptability amongst...

DOI: 10.1111/inm.70010 (opens in new tab) Psychedelic therapy Acceptability Mental health consumer Psychedelic‐assisted therapy +4

Down the Rabbit Hole: A Large-Scale Survey of Psychedelic Users’ Patterns of Use and Perceived Effects

Journal of Psychoactive Drugs January 29, 2025 Carrie Cuttler, Amanda Stueber, Jonathan J. Simone et al. 3 citations

The ever-changing landscape surrounding legality and accessibility of psychedelics and their increasing popularity make it imperative to better understand the nature of psychedelic use by the general population. To this end, 1,486 eligible respondents (Mage = 29.58, 67.1% male) residing in the United States completed an online survey designed to assess the types of psychedelics used, methods of...

DOI: 10.1080/02791072.2025.2452226 (opens in new tab) Acute effects Administration methods Intentions Psychedelics +4

From Theory to Practice: The Importance of Operationalizing and Measuring Ethical Touch in Psychedelic-Assisted Therapy.

The American Journal of Bioethics January 13, 2025 Jason B. Luoma, Jenna Lejeune 6 citations

Neitzke-Spruill et al. (2025) offer an important overview of the ethical considerations around the use of touch within psychedelic assisted therapies (PAT) and MDMA-assisted therapy (MDMA-AT). Thei...

DOI: 10.1080/15265161.2024.2433425 (opens in new tab) Ethical psychedelic therapy Psychedelic medicine ethics Psychedelic psychotherapy ethics Therapeutic well-being +8

PSYCHEDELICS IN THE TREATMENT OF MENTAL DISORDERS

Health and Society January 8, 2025 Eduardo D’avila Lins Lacerda, Bianca Medeiros Ferraz da Nóbrega, Yasmin Mesquita Dias Franca Gadelha et al.

Psychedelics have emerged as a promising approach to treating mental disorders, challenging traditional paradigms in psychiatry. This study conducted an integrative literature review to investigate the advances, challenges, and implications of the therapeutic use of these substances, addressing the guiding question: “What are the current scientific perspectives on the use of psychedelics in the...

Psychotic-Like Experiences in Young Recreational Users of Ketamine: A Case Study.

Journal of Psychoactive Drugs January 8, 2025 Valerio Ricci, Domenico de Berardis, Sheikh Shoib et al. 4 citations

This study explores the psychotic-like experiences (PLEs) associated with recreational ketamine use among young adults. Ketamine, initially introduced as an anesthetic, is now widely used recreationally for its dissociative effects, raising concerns about its impact on mental health. Ten participants aged 18-24, who used ketamine recreationally multiple times a week, were assessed using the...

DOI: 10.1080/02791072.2025.2449909 (opens in new tab) Full text (opens in new tab) Novel psychoactive drugs Psychotic-like symptoms Schizophrenia Ketamine abuse +3